2024-513357-74-01RecruitingPhase 1
Phase 0 trial of CBD in recurrent glioblastoma patients
Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (estimated)
- First submitted
- 26 Jul 2024
- Start date
- 4 Aug 2025
- Lead sponsor
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
- Diseases
- Glioblastoma
- EU CT number
- 2024-513357-74-01
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 7
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.